NCT05728580

Brief Summary

The goal of this study is to discover the potential risk factors related percutaneous coronary intervention. It aims to stratify the risk of PCI patients and discover the prognostic value of these risk fators.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Dec 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Dec 2017Dec 2027

Study Start

First participant enrolled

December 31, 2017

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 6, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 15, 2023

Completed
4.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Expected
Last Updated

March 25, 2024

Status Verified

December 1, 2023

Enrollment Period

5 years

First QC Date

February 6, 2023

Last Update Submit

March 21, 2024

Conditions

Cardiovascular DiseasesPercutaneous Coronary Intervention

Keywords

coronary heart disease

Outcome Measures

Primary Outcomes (2)

  • MACCE

    defined as a composite of all cause mortality, any myocardial infarction (MI), any revascularization, stroke, and heart failure hospitalization

    These data is collected during follow-up for 5 years after discharge

  • All-cause mortality

    whether recidivation happened,whether other related disease happened

    These data is collected during follow-up for 5 years after discharge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with PCI accorrding to Inclusion and exclusion criteria.

You may qualify if:

  • Age greater than or equal to 18 years at the time of admission to the hospital
  • PCI patients with coronary heart disease: according to the criteria interpreted in the 2011 American Guidelines for Percutaneous Coronary Intervention. The successful diagnostic criteria of PCI: residual stenosis of the treated vessel\<10% (preferably 0%), and the forward flow is TIMI grade 3, there is no dissection that affects the flow, no important side branch occlusion, no visible thrombus and peripheral embolism.

You may not qualify if:

  • Patients who failed in PCI treatment;
  • Current known inability to follow instructions or comply with follow-up procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality, 100050, China

RECRUITING

MeSH Terms

Conditions

Cardiovascular DiseasesCoronary Disease

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesVascular Diseases

Study Officials

  • Hongwei Li, Dr

    Beijing Friendship Hospital

    STUDY DIRECTOR

Central Study Contacts

Bingbing Ke, Dr

CONTACT

155102868571017120710@qq.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2023

First Posted

February 15, 2023

Study Start

December 31, 2017

Primary Completion

December 31, 2022

Study Completion (Estimated)

December 31, 2027

Last Updated

March 25, 2024

Record last verified: 2023-12

Locations

CN(1)